Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its target price cut by JPMorgan Chase & Co. from $180.00 to $170.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the specialty pharmaceutical company’s stock. JPMorgan Chase & Co.‘s target price indicates a potential upside […]
Connor Clark & Lunn Investment Management Ltd Cuts Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by Los Angeles Capital Management LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Impax Asset Management Group plc boosted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 17.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,014 shares of the specialty pharmaceutical company’s stock after acquiring an additional 300 shares during […]
Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $217 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.